Barrington Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $19
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Cuts Target Price to $30
Barrington Research Adjusts ModivCare Price Target to $19 From $35, Maintains Outperform Rating
ModivCare Analyst Ratings
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $50
ModivCare Analyst Ratings
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $50
Lake Street Sticks to Their Buy Rating for ModivCare (MODV)
Jefferies Maintains ModivCare(MODV.US) With Hold Rating, Cuts Target Price to $14
ModivCare (MODV) Receives a New Rating From Jefferies
Lake Street Sticks to Their Buy Rating for ModivCare (MODV)
ModivCare Price Target Announced at $35.00/Share by Barrington Research
ModivCare Analyst Ratings
Barrington Research Upgrades ModivCare to Outperform, Announces $35 Price Target
ModivCare: Balancing Financial Results and Strategic Efforts, a Hold Rating Maintained
Lake Street Remains a Buy on ModivCare (MODV)
Lake Street Sticks to Its Buy Rating for ModivCare (MODV)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ocular Therapeutix (OCUL) and ModivCare (MODV)
ModivCare Analyst Ratings
Lake Street Reaffirms Their Hold Rating on ModivCare (MODV)